We are live on ! Find out more
INBP

INTEGRATED BIOPHARMA INC.
INBP

Delisted

INBP was delisted on the 26th of February, 2009.

Back to rankings

1 hedge funds and large institutions have $16K invested in INTEGRATED BIOPHARMA INC. in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

16% less capital invested

Capital invested by funds: $19K → $16K (-$3K)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

INBP Hedge Fund Activity: Q1 2022 in Review

1 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in INTEGRATED BIOPHARMA INC. (INBP) for Q1 2022, worth a combined $16K — down 16% from $19K a quarter earlier.

Fund positioning in INBP was balanced in Q1 2022: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held INTEGRATED BIOPHARMA INC. (INBP) as of Q1 2022, unchanged from Q4 2021.
  • Funds reported $16K of INTEGRATED BIOPHARMA INC. stock for Q1 2022, down 16% quarter-over-quarter.
  • 0 funds opened new INTEGRATED BIOPHARMA INC. positions in Q1 2022 and 0 closed out.

Based on aggregated 13F filings for Q1 2022.